DHR
NYSEDANAHER CORP /DE/
Health Care, Life Sciences Tools & Services
$204.76
close 7 Aug 2026
+2.50%
52-week change
$143.93B
market cap
$160.93
$242.80
52-week range
Valuation
Market cap$143.93B
P/E (TTM / 5y avg)36.30x36.55x
Forward P/E (FY2026 / FY2027)24.06x22.02x
PEG (TTM / fwd)—2.59
P/S (TTM)5.73x
P/B2.74x
EV/EBITDA (TTM)28.90x
FCF yield (TTM)3.80%
Cash flow & dividend
FCF (TTM)$5.47B
FCF per share (TTM)$7.78
FCF margin (TTM)21.77%
Dividend yield (indicated / 5y avg)0.78%0.48%
Annualized dividend$1.60
Payout ratio (EPS / FCF)24.08%17.64%
Growth & quality
Revenue YoY, latest Q+5.54%
Diluted EPS YoY, latest Q+59.74%
Operating margin (TTM)20.42%
Net margin (TTM)15.95%
ROE (latest FY)6.88%
Net debt / EBITDA (TTM)4.50
Interest coverage (TTM)17.56
Price
-26.74%-6.05%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +1.97%10Y CAGR +5.46%
Diluted EPS
5Y CAGR +3.10%10Y CAGR +4.71%
FCF per share
5Y CAGR +2.68%10Y CAGR +8.94%
Operating cash flow
5Y CAGR +0.66%10Y CAGR +5.37%
Free cash flow
5Y CAGR -0.59%10Y CAGR +4.81%
Dividends per share
5Y CAGR +10.90%10Y CAGR +13.83%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -2.49%10Y CAGR -3.62%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date19 Oct 2026bmo
EPS estimate$1.93
Revenue estimate$6.62B
Last reported
Date—
EPS——
Revenue——